Sleep Study Insurance Denied: How to Appeal
Sleep study insurance denied? Appeal polysomnography or home sleep test denials using AASM criteria, clinical risk factors, and this complete guide.
Sleep disorders — particularly obstructive sleep apnea (OSA) — are among the most prevalent and underdiagnosed conditions in the United States, affecting an estimated 25–30 million Americans. Polysomnography (PSG, or "sleep study") and home sleep apnea tests (HSAT) are the diagnostic gold standards for OSA and other sleep disorders. Insurance denials for sleep studies are common, and given that untreated OSA increases risks of hypertension, stroke, atrial fibrillation, cardiovascular disease, and motor vehicle accidents, these denials carry real health consequences.
Types of Sleep Studies and Why They're Denied
In-lab polysomnography (PSG) — overnight study in a sleep laboratory monitoring brain waves (EEG), eye movements, muscle activity, heart rhythm, oxygen saturation, airflow, and respiratory effort. Used for complex cases, children, or when HSAT is inadequate. Cost: $1,000–$5,000. Often denied if insurer claims HSAT is adequate.
Home sleep apnea test (HSAT) — portable device worn at home monitoring airflow, oxygen saturation, respiratory effort, and sometimes heart rate. Appropriate for uncomplicated suspected OSA in adults without significant comorbidities. Cost: $150–$300. Less frequently denied than PSG.
Titration polysomnography (CPAP titration study) — in-lab study to determine optimal CPAP pressure after OSA diagnosis. May be denied if auto-titrating CPAP (APAP) is available.
Split-night study — diagnostic PSG with CPAP titration in the same night if moderate-to-severe OSA is diagnosed. May be denied.
MSLT (Multiple Sleep Latency Test) — tests for narcolepsy and idiopathic hypersomnia. Frequently denied; requires specific documentation of excessive daytime sleepiness and ruling out inadequate sleep.
Why Insurers Deny Sleep Studies
Medical necessity not established. The most common denial. Insurers require documentation of symptoms suggesting OSA: loud snoring, witnessed apneas (observed stopping of breathing during sleep), excessive daytime sleepiness, morning headaches, non-restorative sleep, nocturia. Without these documented in the physician's note, the study may be denied.
Risk stratification tools not used. Validated screening tools like the STOP-BANG questionnaire (scores 0–8) or the Epworth Sleepiness Scale (ESS) objectively assess OSA risk. A STOP-BANG score ≥3 indicates intermediate-to-high risk for OSA. Insurers may require these documented before approving a sleep study.
In-lab PSG denied in favor of HSAT. Most payers prefer HSAT for uncomplicated suspected OSA due to lower cost. If your physician recommends in-lab PSG, the clinical reason must be documented: complex comorbidities (severe heart failure, COPD, neuromuscular disease, oxygen use), prior HSAT that was inconclusive or technically inadequate, clinical suspicion of non-OSA sleep disorder (narcolepsy, PLMD, REM sleep behavior disorder, parasomnias), or inability to set up HSAT independently.
Titration study denied. If auto-titrating CPAP is available, some payers decline to cover a separate titration PSG. For patients with complex anatomy, significant positional or REM-related OSA, or prior APAP failure, in-lab titration is clinically appropriate — document this.
ClaimBack generates a professional appeal letter in 3 minutes — citing real insurance regulations for your country. Get your free analysis →
MSLT denied. For narcolepsy/hypersomnia workups, payers may require documentation of a prior PSG (to rule out sleep deprivation or OSA as the cause of sleepiness), adequate sleep time in the 2 weeks prior (actigraphy or sleep diary), and discontinuation of REM-suppressing medications.
Building Your Sleep Study Appeal
Document Symptoms Comprehensively
Your referring physician's note should explicitly document:
- Snoring severity (nightly, witnessed by bed partner, audible from another room)
- Witnessed apneas or gasping episodes
- Excessive daytime sleepiness (ESS score ≥10 is clinically significant)
- Morning headaches, dry mouth on waking
- Nocturia (waking to urinate, which can be secondary to OSA-induced ANP release)
- Non-restorative sleep, difficulty concentrating, memory impairment
- BMI and neck circumference (NC ≥40 cm in women, ≥43 cm in men is a risk factor)
Include STOP-BANG or ESS Scores
The STOP-BANG questionnaire is an 8-item validated screening tool. Score ≥3 = intermediate risk, ≥5 = high risk. If not already documented, have the physician administer and record the score. Similarly, the Epworth Sleepiness Scale (0–24; >10 suggests pathological sleepiness) provides objective daytime impairment data. Include both in the appeal.
Document Comorbidities
Hypertension, type 2 diabetes, atrial fibrillation, congestive heart failure, coronary artery disease, stroke, obesity, and prior bariatric surgery all increase OSA risk. If these conditions are present, document them as additional clinical justification for testing.
Justify In-Lab PSG Over HSAT
If your physician recommended PSG over HSAT, state the specific clinical reason:
- Prior HSAT was technically inadequate (documented by the sleep center)
- Clinical suspicion of non-OSA sleep disorder
- Severe cardiac, respiratory, or neuromuscular comorbidities
- Need for monitoring beyond airflow/oxygen (e.g., EEG for seizures during sleep, EMG for REM behavior disorder)
Cite the American Academy of Sleep Medicine (AASM) clinical practice guidelines for portable monitoring — they specify the appropriate patient population for HSAT and the clinical situations requiring PSG.
Urgency Arguments
Untreated moderate-to-severe OSA (AHI ≥15) carries independent risk for hypertension, atrial fibrillation, stroke, and fatal cardiovascular events. Commercial vehicle drivers with untreated OSA have a significantly elevated crash risk. If driving safety is a concern, note this in the appeal.
Resources
- American Academy of Sleep Medicine (AASM) (aasm.org) — clinical practice guidelines, patient education
- Sleep Research Society — sleep health advocacy and research resources
- SleepEducation.org (AASM patient resource) — OSA information, CPAP therapy resources
A well-documented sleep study appeal addresses each denial reason directly and provides the objective scoring data insurers require.
Fight Back With ClaimBack
ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word. Fight your denial at ClaimBack →
Related Reading:
How much did your insurer deny?
Enter your denied claim amount to see what you could recover.
Your insurer is counting on you giving up.
Most people do. Less than 1% of denied claimants ever appeal — even though the majority who do win. ClaimBack was built by people who were denied, who fought back, and who refused to accept "no" from an insurer.
We give you the same appeal arguments that attorneys use — in 3 minutes, for free. Your denial deadline is ticking. Don't let it expire.
Free analysis · No credit card · Takes 3 minutes
Related ClaimBack Guides